SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,129 JPY | -1.14% |
|
-4.81% | +4.87% |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| 05-13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
| Sales 2024 | 435B 2.79B 220B | Sales 2025 * | 424B 2.73B 215B | Capitalization | 2,021B 12.98B 1,022B |
|---|---|---|---|---|---|
| Net income 2024 | 162B 1.04B 81.95B | Net income 2025 * | 146B 940M 74.03B | EV / Sales 2024 | 5.05 x |
| Net cash position 2024 * | 473B 3.04B 239B | Net cash position 2025 * | 521B 3.34B 263B | EV / Sales 2025 * | 3.54 x |
| P/E ratio 2024 |
13.9
x | P/E ratio 2025 * |
13.8
x | Employees | 4,959 |
| Yield 2024 * |
2.24% | Yield 2025 * |
2.23% | Free-Float | 87.27% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -1.14% | ||
| 1 week | -4.81% | ||
| Current month | -3.32% | ||
| 1 month | -1.34% | ||
| 3 months | -0.32% | ||
| 6 months | +0.83% | ||
| Current year | +4.87% |
1 week
7 084.00
7 650.00
1 month
7 062.007 650.00
Current year
6 741.008 137.00
1 year
5 718.008 137.00
3 years
5 438.008 439.00
5 years
4 379.008 439.00
10 years
1 852.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 31/03/82 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 31/05/19 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 31/03/82 |
Takuko Sawada
BRD | Director/Board Member | 69 | 01/04/77 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 19 M€ | +11.32% | ||
| 2.51% | 7 M€ | +9.05% | - | |
| 1.07% | 57 M€ | +17.70% | ||
| 1.05% | 10 M€ | +16.22% | - | |
| 1.04% | 240 M€ | +17.87% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/05/24 | 7,129 | -1.14% | 725,400 |
| 16/05/24 | 7,211 | -0.59% | 742,400 |
| 15/05/24 | 7,254 | -0.90% | 1,034,300 |
| 14/05/24 | 7,320 | -4.05% | 1,332,800 |
| 13/05/24 | 7,629 | +1.87% | 995,100 |
Delayed Quote Japan Exchange, May 17, 2024 at 07:00 am
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
06/06/2024
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,129
JPY
Average target price
7,805
JPY
Spread / Average Target
+9.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.87% | 13.17B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 4507 Stock
